Krug, A.; Tari, G.; Saidane, A.; Gaulard, P.; Ricci, J.-E.; Lemonnier, F.; Verhoeyen, E.
Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality. Cancers 2022, 14, 2392.
https://doi.org/10.3390/cancers14102392
AMA Style
Krug A, Tari G, Saidane A, Gaulard P, Ricci J-E, Lemonnier F, Verhoeyen E.
Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality. Cancers. 2022; 14(10):2392.
https://doi.org/10.3390/cancers14102392
Chicago/Turabian Style
Krug, Adrien, Gamze Tari, Aymen Saidane, Philippe Gaulard, Jean-Ehrland Ricci, François Lemonnier, and Els Verhoeyen.
2022. "Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality" Cancers 14, no. 10: 2392.
https://doi.org/10.3390/cancers14102392
APA Style
Krug, A., Tari, G., Saidane, A., Gaulard, P., Ricci, J.-E., Lemonnier, F., & Verhoeyen, E.
(2022). Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality. Cancers, 14(10), 2392.
https://doi.org/10.3390/cancers14102392